// App-Quantinova.ai

2268 : Recurrent Thrombosis Risk in Non-anticoagulated Antiphospholipid Syndrome Patients: A Prospective Case-Control Study from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository (“Registry”)

Researchers

Presenter

  • Cecile Yelnik

Principal Investigators

  • Elodie Drumez

  • Dachi Cheildze

  • Danieli Castro Oliveira de Andrade

  • Ann E Clarke

  • Maria G. Tektonidou

  • Vittorio Pengo

  • Savino Sciascia

  • Amaia Ugarte

  • H Michael Belmont

  • Mª Angeles Aguirre

  • Paul fortin

  • maria gerosa

  • Flavio Victor Signorelli

  • Tatsuya Atsumi

  • Zhouli Zhang

  • Hannah Cohen

  • D. Ware Branch

  • Denis Wahl

  • Laura Andreoli

  • Esther Rodriguez Almaraz

  • Michelle Petri

  • Ricard Cervera

  • Yu Zuo

  • Bahar Artim-Esen

  • Guillermo Pons-Estel

  • Rohan Willis

  • Maria Laura Bertolaccini

  • Robert Roubey

  • Doruk Erkan

Medical Centers

  • Lille 2 University, Lille, France

  • Hospital for Special Surgery, New York, NY.

  • Universite de Lille 3, Lille, France

  • Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, Brazil

  • University of Calgary, Division of Rheumatology, Cumming School of Medicine, Calgary, AB, Canada

  • National and Kapodistrian University of Athens, Athens, Greece

  • Pisa University Hospital, Pisa, Italy

  • University of Turin, Turin, Italy

  • Biocruces Helath Research Institute, Baracaldo, Spain

  • Icahn School of Medicine, New York, NY

  • Maimonides Institute for Biomedical Research of Cordoba IMIBIC, Cordoba, Spain

  • CHU de Québec, Pavillon CHUL, Québec, Canada

  • University of Milan, Milan, Italy

  • IMS, Universidade Estadual do Rio de Janeiro, Rio De Janeiro, Brazil

  • Hokkaido University Hospital, Sapporo, Japan

  • Peking University People's Hospital, Beijing, China

  • Kings College London, London, United Kingdom

  • University of Utah, Salt Lake City, UT

  • Université de Nancy, Nancy, France

  • Rheumatology and Clinical Immunology, Spedali Civili and University of Brescia, Brescia, Italy

  • Hospital Universitario Doce de Octubre, Madrid, Spain

  • Johns Hopkins University School of Medicine, Devision of Rheumatology, Baltimore, MD

  • Hospital Clinic Barcelona, Barcelona, Spain

  • University of Michigan, Ann Arbor, MI

  • Istanbul University, Istanbul, Turkey

  • COR, Rosario, Argentina

  • The University of Texas Medical Branch, Galveston, TX

  • Kings College London, London, United Kingdom

  • University of North Carolina, Chapel Hill, NC

Locations

  • France

  • United States

  • Brazil

  • Canada

  • Greece

  • Italy

  • Spain

  • Japan

  • China

  • United Kingdom

  • Turkey

  • Argentina

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Pulmonary/Respiratory Diseases

  • Congenital disorder

  • Cardiovascular (CVS)

  • Obstetrics/Gynecology

  • Blood/haematological Diseases

Disease

  • Antiphospholipid syndrome

  • Venous thrombosis

  • Twin Anaemia Polycyth aemia Syndrome

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Observational

  • Multinational

  • Multicenteric

  • Prospective

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved